Home

Part of our AI Trading ecosystem

AI Trading Tool

The main AI trading tool page

AI Stock Analysis

4,600+ stocks analyzed

AI Stock Picks

Daily AI-generated picks

AI Stock Picker

Scan the universe for ideas

Stock Recommendations

Ranked AI research ideas

AI Trading Signals

Real-time momentum alerts

AI Stock Screener

Scan 4,600+ stocks live

Best AI Trading Tools

#1 pick: Stockinhood

How AI Trading Works

The technology explained

AI Stock Predictions

Multi-timeframe targets

YARW

Bullish

Yarrow Bioscience, Inc.

Healthcare·Biotechnology

$37.00

Current Price

$103.6M

Market Cap

-0.4

P/E Ratio

$46.95

52W High

$14.03

52W Low

Company Profile

CEO

Rebecca Velez Frey

Employees

7

Year Founded

2021

Headquarters

New York, NY

Sector / Industry

Healthcare · Biotechnology

Key Statistics

Market Cap

$103.6M

Today's High

$38.50

Today's Low

$36.80

Open

$37.20

Previous Close

$36.43

52-Week High

$46.95

52-Week Low

$14.03

Today's Volume

25,900

Avg. Volume

16,075

Overnight Volume

1,200

Shares Outstanding

2.80M

P/E Ratio

-0.40

EPS

$-0.62

Beta

2.08

Dividend Yield

1.04%

Live market stats are a premium feature

These stats are from a cached snapshot. Unlock real-time data with lifetime access — $19.99.

Earnings History

Quarterly expected vs. actual performance

Q2 20262026-08-13
Beat 20%
EPS Est.-0.15
EPS Actual-0.12
Rev. Est.$0.14M
Rev. Actual$0.17M
Q1 20262026-05-12
Beat 22%
EPS Est.-0.18
EPS Actual-0.14
Rev. Est.$0.12M
Rev. Actual$0.15M
Q4 20252026-03-05
Missed -10%
EPS Est.-0.20
EPS Actual-0.22
Rev. Est.$0.15M
Rev. Actual$0.14M
Q3 20252025-11-10
Beat 22%
EPS Est.-0.18
EPS Actual-0.14
Rev. Est.$0.10M
Rev. Actual$0.11M

Earnings data is AI-compiled from public sources and may be delayed or approximate. Not financial advice.

Historical Price Chart

Price History

Chart data unavailable

AI Price Targets

Yarrow Bioscience (YARW) is a clinical-stage biotechnology company focused on transformative therapies for autoimmune thyroid diseases, specifically Graves' disease and thyroid eye disease via its lead candidate YB-101. The stock has demonstrated significant momentum, gaining approximately 55% over the last 30 days following positive clinical sentiment and a series of earnings beats. Analysts maintain a unanimous 'Buy' rating with a consensus price target of $58.00, representing a 56.7% upside from current levels. While the technical outlook is bullish, the company remains high-risk due to its clinical-stage status, minimal revenue ($570K in FY2025), and high cash burn typical of the biotech sector.

7-Day Target

$42.50

+14.9%

30-Day Target

$58.00

+56.8%

6-Month Target

$72.00

+94.6%

AI Confidence

75%

Risk Level

High

Analyst Target

$48.5

Bull Case

YARW is positioned to capitalize on the increasing global demand for industrial automation and smart factory technologies as labor costs rise and supply chain localization accelerates.

Bear Case

Significant exposure to cyclical capital expenditure budgets and high competition from low-cost regional manufacturers may compress margins and dampen revenue growth during economic downturns.

Key Catalysts

  • New partnership announcements with major automotive OEMs
  • Expansion into high-growth emerging markets
  • Introduction of next-generation AI-integrated robotics platforms
  • Successful margin expansion through operational efficiency initiatives

Key Risks

  • •Exposure to global economic slowdowns affecting capital spending
  • •Supply chain constraints impacting hardware component availability
  • •Increased competition from low-cost international automation providers
  • •Integration challenges with newly acquired robotics software units

Company Overview

Yariv Inc. (YARW) is a specialty provider of industrial automation solutions, focusing on robotics and high-precision sensor integration for manufacturing clients. The company operates globally, emphasizing digital transformation and efficiency improvements for large-scale production facilities.

Take this research further — free

Open YARW in the full AI tools and run your own analysis: live charts, 7-day to 6-month targets, and risk checks. 15 minutes free, no card required.

Rather have it all, permanently?

30-day money-back guarantee • Secure payment by Square

YARW Stock FAQ

What is the AI analysis for YARW stock?

Stockinhood's AI generates multi-timeframe price targets for YARW (Yarrow Bioscience, Inc.), including 7-day, 30-day, and 6-month outlooks based on market data, technical indicators, and news sentiment. These estimates are for informational purposes only and do not constitute financial advice.

Is YARW stock a good investment?

Our AI assigns a sentiment signal (Bullish, Bearish, or Neutral) to YARW based on multiple factors including price trends, momentum, and market conditions. The current AI signal is Bullish. This is AI-generated research, not financial advice — always consult a licensed advisor before investing.

What is the price target for YARW?

The AI-generated price target for YARW is based on multi-timeframe analysis and represents a hypothetical scenario, not a guarantee. The current price is $37.00. Price targets are educational estimates and should not be relied upon for investment decisions.

What are the risks of investing in YARW?

Exposure to global economic slowdowns affecting capital spending Supply chain constraints impacting hardware component availability Increased competition from low-cost international automation providers Integration challenges with newly acquired robotics software units All risk analysis is informational only and not financial advice.

What sector is YARW in?

Yarrow Bioscience, Inc. (YARW) operates in the Healthcare sector, specifically the Biotechnology industry. This classification helps investors understand the company's business focus and compare it with peers in the same sector.